Neuroimaging in Lewy body dementia.
Neuroimaging in Lewy body dementia.
复制标题
DOI:
10.1007/s00415-018-8892-x
复制
发表时间:
2019-01
影响因子:
6
通讯作者:
Politis M
中科院分区:
文献类型:
--
作者:
Yousaf T;Dervenoulas G;Valkimadi PE;Politis M
Lewy body dementia (DLB) is a common form of cognitive impairment, accounting for 30% of dementia cases in ages over 65 years. Early diagnosis of DLB has been challenging; particularly in the context of differentiation with Parkinson’s disease dementia and other forms of dementias, such as Alzheimer’s disease and rapidly progressive dementias. Current practice involves the use of [123I]FP-CIT-SPECT, [18F]FDG PET and [123I]MIBG molecular imaging to support diagnostic procedures. Structural imaging techniques have an essential role for excluding structural causes, which could lead to a DLB-like phenotype, as well as aiding differential diagnosis through illustrating disease-specific patterns of atrophy. Novel PET molecular imaging modalities, such as amyloid and tau imaging, may provide further insights into DLB pathophysiology and may aid in early diagnosis. A multimodal approach, through combining various established techniques and possibly using novel radioligands, might further aid towards an in-depth understanding of this highly disabling disease. In this review, we will provide an overview of neuroimaging applications in patients with DLB.
登录
查看更多内容
DOI:
10.1007/s00259-002-0778-5
发表时间:
2002-05-01
影响因子:
9.1
作者:
Colloby, SJ;Fenwick, JD;O'Brien, JT
通讯作者:
O'Brien, JT
DOI:
10.1097/01.jgp.0000236596.56982.1c
发表时间:
2006-10-01
影响因子:
7.2
作者:
Burton, Emma J.;McKeith, Ian G.;O'Brien, John T.
通讯作者:
O'Brien, John T.
影响因子:
9.3
作者:
Albin, Roger L.;Burke, James F.;Frey, Kirk A.
通讯作者:
Frey, Kirk A.
影响因子:
2.4
作者:
Chow N;Aarsland D;Honarpisheh H;Beyer MK;Somme JH;Elashoff D;Rongve A;Tysnes OB;Thompson PM;Apostolova LG
通讯作者:
Apostolova LG
影响因子:
14.5
作者:
Burton, E. J.;Barber, R.;OBrien, J. T.
通讯作者:
OBrien, J. T.